Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Talajic

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
Lancet (London, England)|July 28, 2015
Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trialLaurent Macle, Paul Khairy, Rukshen Weerasooriya, et al.
Journal of the American College of Cardiology|August 9, 2008
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Joseph A Blatt, Jeanne E Poole, George W Johnson, et al.
Circulation. Arrhythmia and Electrophysiology|August 13, 2016
Redefining the Blanking Period After Catheter Ablation for Paroxysmal Atrial Fibrillation: Insights From the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination) TrialStephan Willems, Paul Khairy, Jason G Andrade, et al.
The Canadian Journal of Cardiology|September 10, 2016
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial FibrillationLaurent Macle, John Cairns, Kori Leblanc, et al.
Circulation. Arrhythmia and Electrophysiology|September 5, 2012
Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the cardiac arrest survivors with preserved Ejection Fraction RegistryAndrew D Krahn, Jeffrey S Healey, Vijay S Chauhan, et al.
Circulation|March 22, 2022
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trialRatika Parkash, George A Wells, Jean Rouleau, et al.
Circulation. Arrhythmia and Electrophysiology|September 17, 2016
Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims: A Report From the Cardiac Arrest Survivors With Preserved Ejection Fraction RegistryChristian Steinberg, Gareth J Padfield, Jean Champagne, et al.
The New England Journal of Medicine|September 5, 2008
Prognostic importance of defibrillator shocks in patients with heart failureJeanne E Poole, George W Johnson, Anne S Hellkamp, et al.
Circulation. Cardiovascular Genetics|June 11, 2017
Genetic Testing in the Evaluation of Unexplained Cardiac Arrest: From the CASPER (Cardiac Arrest Survivors With Preserved Ejection Fraction Registry)Greg Mellor, Zachary W M Laksman, Rafik Tadros, et al.
Heart Rhythm|March 25, 2014
Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)Riyaz Somani, Andrew D Krahn, Jeffrey S Healey, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Lancet (London, England)|July 28, 2015
Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trialLaurent Macle, Paul Khairy, Rukshen Weerasooriya, et al.
Journal of the American College of Cardiology|August 9, 2008
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Joseph A Blatt, Jeanne E Poole, George W Johnson, et al.
Circulation. Arrhythmia and Electrophysiology|August 13, 2016
Redefining the Blanking Period After Catheter Ablation for Paroxysmal Atrial Fibrillation: Insights From the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination) TrialStephan Willems, Paul Khairy, Jason G Andrade, et al.
The Canadian Journal of Cardiology|September 10, 2016
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial FibrillationLaurent Macle, John Cairns, Kori Leblanc, et al.
Circulation. Arrhythmia and Electrophysiology|September 5, 2012
Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the cardiac arrest survivors with preserved Ejection Fraction RegistryAndrew D Krahn, Jeffrey S Healey, Vijay S Chauhan, et al.
Circulation|March 22, 2022
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trialRatika Parkash, George A Wells, Jean Rouleau, et al.
Circulation. Arrhythmia and Electrophysiology|September 17, 2016
Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims: A Report From the Cardiac Arrest Survivors With Preserved Ejection Fraction RegistryChristian Steinberg, Gareth J Padfield, Jean Champagne, et al.
The New England Journal of Medicine|September 5, 2008
Prognostic importance of defibrillator shocks in patients with heart failureJeanne E Poole, George W Johnson, Anne S Hellkamp, et al.
Circulation. Cardiovascular Genetics|June 11, 2017
Genetic Testing in the Evaluation of Unexplained Cardiac Arrest: From the CASPER (Cardiac Arrest Survivors With Preserved Ejection Fraction Registry)Greg Mellor, Zachary W M Laksman, Rafik Tadros, et al.
Heart Rhythm|March 25, 2014
Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)Riyaz Somani, Andrew D Krahn, Jeffrey S Healey, et al.
Pageof 21